文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.

作者信息

Rösch W, Liebregts T, Gundermann K-J, Vinson B, Holtmann G

机构信息

Medical Department, North West Hospital, Frankfurt, Germany.

出版信息

Phytomedicine. 2006;13 Suppl 5:114-21. doi: 10.1016/j.phymed.2006.03.022. Epub 2006 Sep 15.


DOI:10.1016/j.phymed.2006.03.022
PMID:16978851
Abstract

Functional gastrointestinal disorders such as functional (or non-ulcer) dyspepsia are characterized by a broad spectrum of symptoms referred to the upper abdomen without a detectable cause utilizing routine diagnostic measures. It is now believed that disordered gut function (including abnormalities like disturbances of motility such as postprandial fundic relaxation, gastric emptying and disturbed visceral sensory function) play a key role for the manifestation of these disorders. The underlying pathophysiology is not yet fully understood. However, the available data suggest that a number of factors may contribute to the manifestation of symptoms. These factors include environmental factors such as acute infections as trigger event, psychological stressors that may precede acute exacerbations and a genetic predisposition. Considering the large number of mechanisms, a treatment targeting a single mechanism is unlikely to be effective in all patients. Indeed, chemically defined treatments usually gain a 10-15% superiority over placebo. In recent years placebo-controlled studies have demonstrated superiority of a commercial multicomponent herbal preparation, STW 5, with the trade name Iberogast, for the treatment of patients with functional dyspepsia and irritable bowel syndrome. This phytopharmacon is a combination of nine plant extracts each with a number of different active constituents. Pharmacological studies have shown different effects of the single plant extracts on the (molecular) mechanisms which are discussed as underlying the manifestation of symptoms. Various well-controlled clinical trials have independently confirmed clinical efficacy and safety. The clinically efficacy of this multicomponent herbal preparation questions the current trend of highly targeted drug molecules that usually target one single receptor population while it has not been shown that a single receptor group plays a pivotal role for the control of symptoms. Herbal medicines are obtained from various plants and contain complex extracts with a large number of different active substances. While there are only limited head-to-head comparisons with conventional chemically defined medications, the combination of extracts with various gastrointestinal active ingredients appears to be advantageous for a heterogeneous condition such as functional dyspepsia.

摘要

相似文献

[1]
Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.

Phytomedicine. 2006

[2]
[Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: a systematic analysis of evidence for the herbal preparation Iberogast].

Wien Med Wochenschr. 2004-11

[3]
[The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].

MMW Fortschr Med. 2004-8-5

[4]
Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).

Aliment Pharmacol Ther. 2004-12

[5]
A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.

Z Gastroenterol. 2002-6

[6]
[A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].

Z Gastroenterol. 2001-7

[7]
[Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].

Z Gastroenterol. 2007-10

[8]
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.

Am J Gastroenterol. 2007-6

[9]
Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.

Wien Med Wochenschr. 2017-5

[10]
Update on the role of drug therapy in non-ulcer dyspepsia.

Rev Gastroenterol Disord. 2003

引用本文的文献

[1]
Herbal Amara extract induces gastric fundus relaxation via inhibition of the M2 muscarinic receptor.

Neurogastroenterol Motil. 2025-1

[2]
From Primary Data to Ethnopharmacological Investigations on subsp. (Wulfen) I.Richardson as a Remedy against Gastric Ailments in Valmalenco (Italy).

Plants (Basel). 2024-2-16

[3]
Dietary therapy of the herbal porridge improves the symptoms of functional dyspepsia: A randomized, double-blind, placebo-controlled, clinical trial.

Food Sci Nutr. 2024-1-7

[4]
Herbal medicine, , for functional dyspepsia: a systematic review and meta-analysis.

Front Pharmacol. 2023-5-19

[5]
Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Drugs. 2020-9

[6]
STW 5 is effective against nonsteroidal anti-inflammatory drugs induced gastro-duodenal lesions in rats.

World J Gastroenterol. 2019-10-21

[7]
The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract.

Int J Mol Sci. 2019-10-24

[8]
Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials.

Nutrients. 2018-11-9

[9]
Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews.

Therap Adv Gastroenterol. 2018-7-16

[10]
Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.

Planta Med. 2017-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索